Showing results (171-180 of 234) with videos related to

Sort By:
Pageof 24
Nature Communications|April 29, 2014
Klf4 and Klf5 differentially inhibit mesoderm and endoderm differentiation in embryonic stem cellsIrène Aksoy, Vincent Giudice, Edwige Delahaye, et al.
Plos One|January 7, 2014
Application of multi-SNP approaches Bayesian LASSO and AUC-RF to detect main effects of inflammatory-gene variants associated with bladder cancer riskEvangelina López de Maturana, Yuanqing Ye, M Luz Calle, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
BPTF cooperates with MYCN and MYC to link neuroblastoma cell cycle control to epigenetic cellular statesIrene Felipe, Jaime Martínez-de-Villarreal, Khushbu Patel, et al.
Cancer Research|January 9, 2020
Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid FeaturesMiriam Marqués, Robin Tranchant, Blanca Risa-Ebrí, et al.
Epigenetics|December 9, 2014
LINE-1 methylation in granulocyte DNA and trihalomethane exposure is associated with bladder cancer riskLucas A Salas, Cristina M Villanueva, Salman M Tajuddin, et al.
Lancet (London, England)|August 23, 2005
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analysesMontserrat García-Closas, Núria Malats, Debra Silverman, et al.
The Journal of Clinical Investigation|January 10, 2015
NOTCH pathway inactivation promotes bladder cancer progressionAntonio Maraver, Pablo J Fernandez-Marcos, Timothy P Cash, et al.
Plos One|May 14, 2014
Genetic variation in the TP53 pathway and bladder cancer risk. a comprehensive analysisSilvia Pineda, Roger L Milne, M Luz Calle, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 25, 2015
International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancerKyoichi Takaori, Claudio Bassi, Andrew Biankin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2026
Phase I trial of intravenous VCN-01 oncolytic adenovirus and durvalumab in patients with head and neck metastatic squamous cell carcinoma refractory to immunotherapyMaria Jove, Irene Braña, Marc Oliva, et al.
Pageof 24